Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-01

Clinical Trial Update: Gametocytocidal and Transmission-blocking Efficacy of ASAQ and ALAQ With or Without PQ in Mali [Phase 2]

View source ↗

Summary

A Phase 2 trial in Mali evaluating the gametocytocidal and transmission-blocking effects of ASAQ and ALAQ with or without primaquine in falciparum malaria. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALAQ
  • ASAQ (amodiaquine-artesunate)
  • Primaquine (primaquine)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria,Falciparum | Phase 2 | Status: COMPLETED